Moreover, PZQ is reported to prevent the development of pulmonary arterial hypertension associated with S. mansoni infection [11] and reverse the changes of severe pulmonary vascular remodeling associated with perivascular inflammation by reducing mRNA levels of inflammatory cytokines IL-13, IL-8, and IL-4 in lungs [12]. The gene discussed is IL4; the disease is pulmonary arterial hypertension.